Revelation Biosciences Inc Cash Flow Quality Index
Revelation Biosciences Inc cash flow quality index. Revelation Biosciences Inc (REVB) has a Cash Flow Quality Index of -0.26x as of March 2023. Operating cash flow of $-1.58 Million is below net income of $6.16 Million, suggesting accrual-heavy earnings not yet converted to cash. See Revelation Biosciences Inc financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Revelation Biosciences Inc (2015–2018)
Cash flow quality index of Revelation Biosciences Inc from 2015 to 2018. Historical Cash Flow Quality Index for Revelation Biosciences Inc across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Revelation Biosciences Inc (REVB) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Revelation Biosciences Inc Cash Flow Quality Index by Year (2015–2018)
Revelation Biosciences Inc cash flow quality index by year from 2015 to 2018. Year-by-year earnings quality comparison for Revelation Biosciences Inc. For the full cash flow conversion analysis, see Revelation Biosciences Inc operating cash flow efficiency.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2018 | 1.18x | $32.58 Million | $27.63 Million | ▼ -20.9% |
| 2017 | 1.49x | $24.25 Million | $16.27 Million | ▲ +12.8% |
| 2016 | 1.32x | $11.60 Million | $8.78 Million | ▼ -29.3% |
| 2015 | 1.87x | $11.60 Million | $6.20 Million | — |